Search Results - "BJORNEBOE, Olav"

Treat to target strategy in early rheumatoid arthritis versus routine care – A comparative clinical practice study by Brinkmann, Gina Hetland, Norvang, Vibeke, Norli, Ellen Sauar, Grøvle, Lars, Haugen, Anne Julsrud, Lexberg, Åse Stavland, Rødevand, Erik, Bakland, Gunnstein, Nygaard, Halvor, Krøll, Frode, Widding-Hansen, Inger Johanne, Bjørneboe, Olav, Thunem, Cathrine, Kvien, Tore, Mjaavatten, Maria Dahl, Lie, Elisabeth

“…To assess the 2-year effect on disease activity and health-related quality of life (HRQoL) of implementing a clinical practice treat-to-target (T2T) strategy…”
Get full text

Joint Distribution and Two‐Year Outcome in 347 Patients With Monoarthritis of Less Than Sixteen Weeks’ Duration by Norli, Ellen Sauar, Brinkmann, Gina Hetland, Kvien, Tore Kristian, Bjørneboe, Olav, Haugen, Anne Julsrud, Nygaard, Halvor, Thunem, Cathrine, Lie, Elisabeth, Mjaavatten, Maria Dahl

“…Objective The present study was undertaken to investigate the joint distribution and 2‐year outcome of patients with recent‐onset monoarthritis. Methods Adult…”
Get full text

Role of erosions typical of rheumatoid arthritis in the 2010 ACR/EULAR rheumatoid arthritis classification criteria: results from a very early arthritis cohort by Brinkmann, Gina Hetland, Norli, Ellen S, Bøyesen, Pernille, van der Heijde, Désirée, Grøvle, Lars, Haugen, Anne J, Nygaard, Halvor, Bjørneboe, Olav, Thunem, Cathrine, Kvien, Tore K, Mjaavatten, Maria D, Lie, Elisabeth

“…To determine how the European League Against Rheumatism (EULAR) definition of erosive disease (erosion criterion) contributes to the number of patients…”
Get more information

Disease Characteristics and Rheumatoid Arthritis Development in Patients with Early Undifferentiated Arthritis: A 2-year Followup Study by Brinkmann, Gina H, Norli, Ellen S, Kvien, Tore K, Haugen, Anne J, Grøvle, Lars, Nygaard, Halvor, Bjørneboe, Olav, Thunem, Cathrine, Mjaavatten, Maria D, Lie, Elisabeth

“…To examine the 2-year disease course in patients with undifferentiated arthritis (UA) focusing on fulfillment of the 2010 American College of…”
Get full text

Self-limiting arthritis among patients fulfilling the 2010 ACR/EULAR classification criteria for rheumatoid arthritis in a very early arthritis cohort by Norli, Ellen S, Brinkmann, Gina H, Kvien, Tore K, Bjørneboe, Olav, Haugen, Anne J, Nygaard, Halvor, Thunem, Cathrine, Lie, Elisabeth, Mjaavatten, Maria D

“…Abstract Objectives To study occurrence of and factors associated with self-limiting arthritis among patients fulfilling the 2010 ACR/EULAR classification…”
Get full text

Should Anti-citrullinated Protein Antibody and Rheumatoid Factor Status Be Reassessed During the First Year of Followup in Recent-Onset Arthritis? A Longitudinal Study by MJAAVATTEN, Maria D, VAN DER HEIJDE, Desiree M, UHLIG, Till, HAUGEN, Anne J, NYGAARD, Halvor, BJØRNEBOE, Olav, KVIEN, Tore K

“…Presence and levels of antibodies contribute to the classification of rheumatoid arthritis. We investigated the longitudinal course of anti-citrullinated…”
Get full text

Involvement of the multidisciplinary team and outcomes in inpatient rehabilitation among patients with inflammatory rheumatic disease by Uhlig, Till, Bjørneboe, Olav, Krøll, Frode, Palm, Øyvind, Olsen, Inge Christoffer, Grotle, Margreth

“…The last decades have for patients with inflammatory rheumatic diseases seen a shift towards more physically active rehabilitation programs, often provided as…”
Get full text

Diagnostic spectrum and 2-year outcome in a cohort of patients with very early arthritis by Norli, Ellen Sauar, Brinkmann, Gina Hetland, Kvien, Tore Kristian, Bjørneboe, Olav, Haugen, Anne Julsrud, Nygaard, Halvor, Thunem, Cathrine, Lie, Elisabeth, Mjaavatten, Maria Dahl

“…ObjectivesTo describe the diagnostic spectrum, arthritis persistency and clinical outcomes after 2 years in patients with inflammatory arthritis (IA) of less…”
Get full text

Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis by Tubach, Florence, Pham, Thao, Skomsvoll, Johan F., Mikkelsen, Knut, BjØrneboe, Olav, Ravaud, Philippe, Dougados, Maxime, Kvien, Tore K.

“…Objective The Patient Acceptable Symptomatic State (PASS) is the highest level of symptoms beyond which patients consider themselves well. It provides…”
Get full text

The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational study by Westhovens, R, van Vollenhoven, R F, Boumpas, D T, Brzosko, M, Svensson, K, Bjorneboe, O, Meeuwisse, C M, Srinivasan, S, Gaudin, P, Smolen, J S, Rahman, M U, Nelissen, R L, Vastesaeger, N

“…We aimed to describe patterns of disease activity during infliximab plus methotrexate (MTX) treatment and explore C-reactive protein (CRP) as a potential…”
Get full text

Transdermal fentanyl for the treatment of pain caused by rheumatoid arthritis by HERRERO-BEAUMONT, Gabriel, BJORNEBOE, Olav, RICHARZ, Ute

“…This study evaluated transdermal fentanyl (TDF) for the treatment of pain from rheumatoid arthritis (RA) which was not adequately controlled by nonopioid…”
Get full text

Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control by Pavelka, Karel, Loet, Xavier Le, Bjorneboe, Olav, Herrero-Beaumont, Gabriel, Richarz, Ute

“…SUMMARY Objectives: To evaluate the effectiveness and safety of transdermal fentanyl (TDF) for the treatment of pain associated with rheumatoid arthritis (RA)…”
Get full text

Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies by Hawkey, Christopher J, Talley, Nicholas J, Scheiman, James M, Jones, Roger H, Långström, Göran, Naesdal, Jorgen, Yeomans, Neville D

“…Non-steroidal anti-inflammatory drugs (NSAIDs), including selective cyclo-oxygenase-2 (COX-2) inhibitors, cause upper gastrointestinal (GI) symptoms that are…”
Get full text

Minneord by Ekeland, Arne, Prøven, Anne, Helgetveit, Knut, Bjørneboe, Olav, Nabizadeh, Shagaye

Get full text

Efficacy and safety of meloxicam in patients with rheumatoid arthritis by Lemmel, E M, Bolten, W, Burgos-Vargas, R, Platt, P, Nissilä, M, Sahlberg, D, Björneboe, O, Baumgartner, H, Valat, J P, Franchimont, P, Bluhmki, E, Hanft, G, Distel, M

“…To evaluate the efficacy and safety of meloxicam, a new acidic enolic nonsteroidal anti-inflammatory drug, at doses of 7.5 and 15 mg once daily in patients…”
Get more information

Duration of morning stiffness in rheumatic patients after medication with enteric-coated and plain naproxen tablets by Johnsen, V, Bjerkhoel, F, Bjørneboe, O, Børresen, B, Finstad, R, Hansen, K, Moen, F

“…Twenty-nine adult rheumatic patients who were taking 500 mg naproxen at bedtime and had a certain degree of morning stiffness despite this medication took part…”
Get more information